Թ

subscribe

Findings suggest that certain medications for Type 2 diabetes reduce risk of dementia

A large Թ study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.

Email address:
Published: 15 Jan 2026

Three Թ researchers receive SSHRC Partnership Engage Grants

The Social Science and Humanities Research Council of Canada (SSHRC) announced recipients of the latest Partnership Engage Grants competition, including a total of $73,782 awarded to three Թ researc

Email address:
Published: 14 Jan 2026

New evidence challenges understanding of Parkinson’s disease

A Թ-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson’s disease treatments.

Email address:
Published: 17 Dec 2025

Fine particles in pollution are associated with early signs of autoimmune disease

A new study has linked air pollution exposure and immune-system changes that often precede the onset of autoimmune diseases.

Թ researchers analyzing Ontario data found that fine particles in air pollution are associated with higher levels of a biomarker linked with autoimmune diseases, such as systemic lupus.

Published: 15 Dec 2025

Amazing Brain Science Talks 2025: Exploring Brain-Heart Connections

On Saturday, November 8, 2025, Healthy Brains, Healthy Lives (HBHL) presented the third edition of the Amazing Brain Science Talks, in partnership with Brain Canada Foundation and the Brain-Heart Interconnectome.

Published: 10 Dec 2025

Թ moves up to third overall in Research Infosource rankings, maintains its No. 2 position for medical research

The University continues to be recognized as one of Canada’s top research institutions and drivers of innovation

Published: 4 Dec 2025

Group therapy helps cancer survivors reclaim life after treatment

A program developed by a Թ researcher to help cancer survivors cope with the fear their cancer will return is expanding across Canada.

The Fear of Recurrence Therapy (FORT) program offers evidence-based support to address what co-founder Christine Maheu calls one of the most overlooked aspects of recovery.

Email address:
Published: 3 Dec 2025

News

Published: 3 Nov 2022

Pages

Back to top